Browsing Tag
Alvotech
7 posts
Is Alvotech about to reshape Europe’s anti-TNF market with its Simponi biosimilar?
Alvotech and STADA launch Europe’s first Simponi biosimilar, Uzpruvo. Find out how this shifts competition in the €1B+ anti-TNF therapy market.
December 22, 2025
FDA accepts Alvotech and Teva’s BLA for AVT05, advancing first golimumab biosimilar in the U.S.
FDA accepts Alvotech and Teva’s BLA for AVT05, a proposed golimumab biosimilar — find out how this milestone strengthens U.S. biosimilar competition.
November 3, 2025
U.S. stocks rally but key names fall: MicroAlgo, Unity, Reddit among top losers on April 14
Despite a market rally, major names like Unity, Reddit, and LVMH fell sharply. Find out what triggered losses across tech, retail, and biotech stocks.
April 15, 2025
MicroAlgo crashes 20%, Trump Media slips again—here’s why markets panicked
Explore why 25 top U.S.-listed stocks tumbled on April 2 as Trump’s tariff strategy ignited fears of inflation, recession, and global retaliation.
April 3, 2025
GameStop, AppLovin, and New Fortress Energy lead market declines on March 27
Discover why GameStop, AppLovin, and other major U.S. stocks suffered steep losses on March 27, 2025. Explore industry insights and market trends shaping investor sentiment.
March 28, 2025
FDA approves Alvotech and Teva Pharmaceuticals’ SELARSDI as biosimilar to Stelara
In a significant development in the pharmaceutical industry, Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of…
April 17, 2024
FDA approves biosimilar SIMLANDI by Alvotech and Teva Pharmaceuticals
Alvotech and Teva Pharmaceuticals have achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval…
February 25, 2024